We delve into the CDC’s move to recommend fewer vaccines in the childhood immunization schedule, one of the most significant steps taken by the Kennedy administration so far. The change is sparking strong reactions across the spectrum, and we aim to understand why it’s happening, what evidence is being used to justify it, and what the potential consequences could be for children, parents, and public trust.

The administration says it looked to models abroad, particularly Denmark, where fewer vaccines are recommended. So we invited two Danish physicians who know their country’s vaccine policy and practice, along with a friend of the show, Dr. Michael Mina.

We ask: Is Denmark — a far smaller country with universal health care — really a good model for U.S. vaccine policy? Was this change grounded in gold-standard science? Or, as mainstream public health warns, does it increase risk for American children, even though all vaccines remain available and covered? And what, if anything, can the U.S. learn from countries that recommend fewer vaccines?

Hosts:

Brinda Adhikari

Tom Johnson

Maggie Bartlett

Dr. Mark Abdelmalek

Guests:

Dr. Eskild Petersen, an infectious disease specialist who worked 14 years at the Statens Serum Institut moving back into clinical ID in 2003. Since 2024 adjunct professor at PandimiX Center, Roskilde University, Denmark. Leading author of "Infectious Diseases, A Geographical Guide (Rutledge 2024) and editor in chief of the International Journal of Infectious Diseases.

Dr. Lone Graff Stensballe, a consultant pediatrician and expert in pediatric infectious diseases, with over 20 years of clinical experience at the pediatric department of Denmark’s National University Hospital. She is Professor of Pediatric Vaccinology and Infectious Disease Epidemiology at the University of Copenhagen. Since 2018, she has served as Chair of the Research Ethics Committees in Denmark.

Dr. Michael Mina, an epidemiologist and immunologist and physician. Over the course of his career, he’s been an associate professor at Harvard Medical School as well as the TH Chan School of Public Health. In the height of the pandemic, he led America’s Test to Treat program, which connected home testing to treatment options. He’s been a scientific advisor for health start-ups and has served on high-profile boards.

Thanks for listening! If you like us, please leave a review, rate us, and please subscribe!

Got questions? Comments? We'd love to hear from you! Email us at questions@whyshoulditrustyou.net

CES 2026 - The Best of CES - DTNS 5181

DTNS Live

PC & Case Innovations

The AI-powered Podcast Player